IA
EXAS

IFP Advisors’s Exact Sciences EXAS Stock Holding History

IFP Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,655
Closed -$174K – 5186
2026
Q1 		$174K Hold
1,655
– – ﹤0.01% 1473
2025
Q4 		$168K Sell
1,655
-767
-32% -$61.6K ﹤0.01% 1469
2025
Q3 		$133K Sell
2,422
-2,044
-46% -$102K ﹤0.01% 1510
2025
Q2 		$237K Buy
4,466
+273
+7% +$13.9K 0.01% 1185
2025
Q1 		$182K Sell
4,193
-35,190
-89% -$1.78M 0.01% 1219
2024
Q4 		$2.21M Buy
39,383
+39,067
+12,363% +$2.43M 0.07% 315
2024
Q3 		$21.6K Buy
316
+91
+40% +$5.14K ﹤0.01% 2116
2024
Q2 		$9.52K Buy
225
+70
+45% +$3.85K ﹤0.01% 2357
2024
Q1 		$10.7K Buy
155
+2
+1% +$127 ﹤0.01% 2209
2023
Q4 		$11.3K Sell
153
-93
-38% -$6.1K ﹤0.01% 2148
2023
Q3 		$16.8K Buy
246
+85
+53% +$7.21K ﹤0.01% 2024
2023
Q2 		$15.1K Sell
161
-429
-73% -$33.5K ﹤0.01% 2139
2023
Q1 		$35.1K Sell
590
-3,502
-86% -$225K ﹤0.01% 1756
2022
Q4 		$250K Buy
4,092
+604
+17% +$24.7K 0.01% 1238
2022
Q3 		$218K Buy
3,488
+1,316
+61% +$54.3K 0.01% 1354
2022
Q2 		$139K Hold
2,172
– – ﹤0.01% 1488
2022
Q1 		$139K Buy
2,172
+1,229
+130% +$89.8K ﹤0.01% 1488
2021
Q4 		$74K Sell
943
-1,049
-53% -$92.6K ﹤0.01% 1391
2021
Q3 		$189K Buy
1,992
+299
+18% +$31.6K ﹤0.01% 978
2021
Q2 		$208K Buy
1,693
+238
+16% +$28.4K ﹤0.01% 886
2021
Q1 		$194K Buy
1,455
+451
+45% +$61.7K ﹤0.01% 851
2020
Q4 		$135K Buy
1,004
+21
+2% +$2.54K 0.01% 985
2020
Q3 		$102K Sell
983
-85
-8% -$7.34K 0.01% 982
2020
Q2 		$90K Buy
1,068
+570
+114% +$45.5K 0.01% 962
2020
Q1 		$31K Sell
498
-309
-38% -$25.1K ﹤0.01% 1320
2019
Q4 		$77K Sell
807
-3,618
-82% -$318K 0.01% 1065
2019
Q3 		$405K Buy
+4,425
New +$504K 0.03% 543
2019
Q1 		$202K Sell
2,294
-4,327
-65% -$368K 0.03% 468
2018
Q4 		$405K Buy
6,621
+429
+7% +$29.4K 0.02% 623
2018
Q3 		$489K Buy
6,192
+2,047
+49% +$133K 0.02% 667
2018
Q2 		$248K Sell
4,145
-13,789
-77% -$742K 0.01% 957
2018
Q1 		$942K Hold
17,934
– – 0.04% 409
2017
Q4 		$942K Sell
17,934
-9,559
-35% -$510K 0.04% 409
2017
Q3 		$1.29M Buy
27,493
+13,643
+99% +$549K 0.05% 369
2017
Q2 		$490K Buy
13,850
+10,517
+316% +$325K 0.02% 689
2017
Q1 		$79K Buy
3,333
+2,940
+748% +$58.3K ﹤0.01% 1652
2016
Q4 		$5K Sell
393
-2,290
-85% -$37K ﹤0.01% 3283
2016
Q3 		$50K Sell
2,683
-10,236
-79% -$180K ﹤0.01% 1815
2016
Q2 		$158K Buy
12,919
+10,625
+463% +$80K 0.01% 1092
2016
Q1 		$202K Sell
2,294
-10,325
-82% -$66.1K 0.03% 468
2015
Q4 		$116K Buy
+12,619
New +$117K 0.01% 1094

IFP Advisors's EXAS Position: Q2 2026 in Review

IFP Advisors sold out of Exact Sciences (EXAS) in Q2 2026, closing a stake of 1,655 shares — an estimated $174K sold.

IFP Advisors first reported a position in EXAS in Q4 2015 and held it in 41 quarters. The position peaked at $2.21M in Q4 2024. 0 funds tracked by Wall St. Rank hold EXAS as of Q2 2026.

  • IFP Advisors reported no remaining Exact Sciences position as of Q2 2026 after selling out during the quarter.
  • IFP Advisors sold 1,655 Exact Sciences shares in Q2 2026, an estimated $174K.
  • IFP Advisors first reported a position in Exact Sciences in Q4 2015 and held it in 41 quarters.
  • IFP Advisors's Exact Sciences position peaked at $2.21M in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.